Wen Shen, MD, describes perimenopause as an opportunity for clinicians to revisit pregnancy-related risk factors and address cardiovascular health proactively.
Poll|Poll|January 1, 2025
Poll: What content from Contemporary OB/GYN do you want to see in 2025?
Author(s)Celeste Krewson, Assistant Editor
As we prepare to bring you obstetric and gynecology news this year, what topics would you like to hear more about?
Advertisement
What topics would you like increased coverage of in 2025?
Advertisement
Related to this article
A recap of the top videos and podcasts from Contemporary OB/GYN in September 2026, featuring expert interviews on salpingectomy, testosterone evidence, and more.
A new study finds that low birth volume and unprofitability were strongly associated with both obstetric unit and full hospital closures between 2010 and 2023.
A recap of the top headlines from Contemporary OB/GYN in September 2026, spanning ACOG's respiratory vaccine guidance to the launch of the Missed & Dismissed podcast.
A recap of Contemporary OB/GYN's top FDA and regulatory news from September 2026.
Fezolinetant was linked to VMS and sleep improvements by week 4 in the real-world OPTION-VMS study, presented at the International Menopause Society World Congress.
Wen Shen, MD, highlights perimenopause as an important period for identifying health risks and supporting healthy aging beyond the menopausal transition.
A global consensus published in The Lancet has officially renamed polycystic ovary syndrome to polyendocrine metabolic ovarian syndrome, a change with broad implications for diagnosis, care, and cardiometabolic screening.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Wen Shen, MD, highlights pregnancy, comorbidity history in perimenopause care
2
IMS: Fezolinetant's improvements in sleep quality, hot flashes as early as week 4
3
Preeclampsia Foundation launches postpartum recovery videos for HDP
4
Wen Shen, MD, on recognizing perimenopause as a window for healthy aging
5